ASCAPE is an EC H2020 Research and Innovation Action (Grant Agreement ID: 875351) with the main objective to take advantage of the recent ICT advances in Big Data, Artificial Intelligence, and Machine Learning to support cancer patients’ quality of life and health status. To achieve its objective, ASCAPE will create an open AI infrastructure that will enable health stakeholders (hospitals, research institutions, companies, etc.) to deploy and execute its AI algorithms locally on their private data.
The ASCAPE project will be developed in 36 months by a competitive consortium of 15 partners from 7 countries, which corresponds to a well-balanced structure, involving big companies, SMEs, research centers, and universities.
*Any related posts reflect only the views of the project owner.
Company Details
- Founded
- -
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://ascape-project.eu
- Keywords
- Big Data, Data Driven Analytics, Artificial Intelligence, Machine Learning, Quality of Life, Health Status, Health Economic Data, Heath Care metadata, Cancer care prediction, Intelligent Systems.
- Competitors
- UPSCALE, BioSense Institute, DOUBLE HASHING.
Ascape H2020 Questions
Ascape H2020's website is http://ascape-project.eu
Ascape H2020's LinkedIn profile is https://www.linkedin.com/company/ascape-h2020
Ascape H2020's industry is
Research Services
Ascape H2020's categories are Research Services
Ascape H2020's founding year is 2020
